Skip to main content

CorMedix Inc.

CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001410098

No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding CorMedix Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CRMD: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7473−1
Shares12.4M11.0M−1.41M (−11.4%)
Value$49.4M$31.3M−$18.1M (−36.6%)

New holders (12)

Institutions that held CorMedix Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CRMD in Q3 2022
InstitutionSharesValue% of portfolio
Tower Research Capital LLC (TRC)45,696$129.0K0.00%
Group One Trading, L.P.39,163$111.0K0.00%
Portland Investment Counsel Inc.39,000$110.0K0.07%
HBK Sorce Advisory LLC73,750$75.0K0.01%
ARS Wealth Advisors Group, LLC11,000$70.0K0.01%
First Foundation Advisors16,640$47.0K0.00%
ExodusPoint Capital Management, LP15,298$43.0K0.00%
Renaissance Technologies LLC13,600$38.0K0.00%
Pinnacle Associates Ltd10,000$28.0K0.00%
Pinnacle Wealth Management Advisory Group, LLC10,000$28.0K0.00%
UBS Group AG7,641$22.0K0.00%
Royal Bank of Canada16$00.00%

Sold out (13)

Institutions that held CorMedix Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of CRMD in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Wick Capital Partners, LLC114,697$461.0K
Veritable, L.P.53,550$215.0K
Walleye Capital LLC48,000$193.0K
Goldman Sachs Group Inc26,193$105.0K
Boothbay Fund Management, LLC10,360$42.0K
StoneX Group Inc.10,415$41.9K
Quantbot Technologies LP5,600$22.0K
Captrust Financial Advisors1,679$7.00K
Baron Financial Group, LLC1,000$4.02K
Citigroup Inc386$2.00K
New York State Common Retirement Fund268$1.00K
Credit Suisse AG20$0
Ellevest, Inc.37$0